Articles tagged with Dna Vaccination
Researchers have developed a new TB vaccine by fusing a Mycobacterium tuberculosis antigen with a gene that highly expresses a thiol-specific-antioxidant protein from Leishmania major. This hybrid DNA vaccine increased protein production, leading to a more robust immune response in mice.
The Sequella Global Tuberculosis Foundation has awarded $500,000 in grants to nine researchers working on innovative tuberculosis vaccines. The grants will fund projects using novel adjuvants, delivery mechanisms, and immunological approaches.
A team of researchers at NIH has developed a novel vaccine that prevents Ebola virus infection in monkeys, offering a promising new approach to protecting humans. The vaccine induces strong anti-Ebola immune responses and protects against lethal doses of the virus.
A DNA vaccine paired with an immune protein successfully controls a highly pathogenic AIDS virus in monkeys, strengthening their immune response and preventing disease. The approach could decrease HIV-1 transmission rates by reducing viral replication in vaccinated individuals.
A DNA-based flu vaccine has shown promising results in a mouse study, generating high levels of neutralizing antibodies and providing protection at a lower dose. The vaccine combines C3d with HA glycoprotein, priming the immune system against influenza.
The National Institute of Allergy and Infectious Diseases has launched four public-private partnerships to accelerate the development of promising HIV/AIDS vaccines. The partnerships aim to tap into the skills of both private industry and academic research centers, with a focus on developing vaccines for use around the world.
A new DNA vaccine has been developed to protect North American salmon and trout farms from a major disease, with successful trials showing 90% reduction in mortality. The vaccine works by introducing DNA containing the gene for one of the viral proteins, which is then taken up by cells and produces the protein to prime the immune system.
A DNA vaccine developed by Emory University researchers protects monkeys against HIV challenge infections, demonstrating a promising step towards an effective AIDS vaccine. The vaccine uses a two-step approach, priming the immune system with a DNA vaccine and followed by booster immunizations with a pox virus.
A DNA vaccine against rabies has shown complete protection in eight vaccinated monkeys, offering new hope for global eradication of the deadly disease. The vaccine also elicited neutralizing antibodies that could potentially protect humans and animals.
Researchers at the University of Pennsylvania School of Medicine are conducting a new clinical trial combining a proven antiretroviral drug therapy with an experimental DNA vaccine to eradicate HIV. The therapy has shown promise in lowering virus levels and restoring immune system function, paving the way for a potential cure.